For chemical compatibility see, Filter Vial & Membrane Chemical Compatibility Index

Thomson Filter Vials are designed for small-volume sterilization and clarification of pharmacy solutions for analytical analysis. Please search the index below to find the Filter Vial suitable to your needs.

Drug Name Membrane Pore Size Cap Color Cross Referance Article
{{ d.drugName }} {{ d.membrane }} {{ d.poreSize }}μm {{ r }}

References

  1. Santini, A. O. et al. (2004). p-Aminobenzoate ion determination in pharmaceutical formulations by using a potentiometric sensor immobilized in a graphite matrix. Talanta 63:833-838.
  2. Bosanquet, A.G. (1985) Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents. Cancer Chemother. Pharmacol. 14:83-95
  3. Capello, B. et al. (2001) Solubilization of tropicamide by hydroxypropyl-[beta]-cyclodextrin and water-soluable polymers: in vitro/in vivo studies. Int. J. Pharm.213:75-81.
  4. Butler, L.D., et al (1980). Effect of inline filtration on the potency of low-dose drugs. Am. J. Hosp. Pharm. 37:935-941.
  5. Chang, C.W., et al.(2007). A robotic synthesis of [18F]fluoromisonidazole([18F]FMISO), Applied Radiation and Isotopes, In Press, Accepted Manuscript, Available online 6 February.
  6. Fagny, C., et al. (2002). Ribonucleotide reductase and thymidine phosphorylation: two potential targets of azodicarbonamide. Biochem. Pharmacol. 64: 451-456.
  7. et al. (2003). Fluoro-, bromo-, iodopaclitaxel derivatives: synthesis and biological evaluation. Nuclear Medicine and Biology. 30: 11-24.
  8. Elenbaas, J.K., et al. (1985). Effect of inline filtration on tobramycin delivery. Drug Intell. Clin. Pharm. 19: 122-125.
  9. Ennis, C.E., et al. (1983) In vitro study of inline filtration of medications commonly administered to pediatric cancer patients. J. Parenter Enter.Nutr. 7: 156-158.
  10. Lallemand, et. al. (2005) A novel water-soluble cyclosporine A prodrug: Ocular tolerance and in vivo kinetics. Int.J.Pharm. 295: 7-14.
  11. Verreck, G., et al. (2005). Preparation and physicochemical characterization of biodegradable nerve guides containing the nerve growth agent sabeluzole. Biomaterials 26: 1307-1315.
  12. Flaten, G.E., et al. (2006) Drug permeability across a phospholipid vesicle based barrier. A novel approach for studying passive diffusion. European Journal of Pharmaceutical Sciences 27: 80-90.
  13. Grant, A.M.(1987). Personal communication.
  14. Huber, R.C. and Riffkin, C. (1975) Inline final filters for removing particles from amphotericin B infusions. Am.J.Hosp.Pharm. 32: 173-176.
  15. Toro, I. et al. (2004). Development and validation of a capillary electrophoresis method with ultraviolet detection for the determination of the related substances in a pharmaceutical compound. J. Chromatogr. A 1043: 303-315
  16. Calleja, I. et al. (2004). High–performance liquid-chromatographic determination of rifampicin in plasma and tissues. J. Chromatogr. 1031: 289-294.
  17. Gennaro, M.C., et al. (2001) Ion interaction reagent reversed-phase high-performance liquid chromatography determination of anti-tuberculosis drugs and metabolites in biological fluids. J. Chromatogr. B 754: 477-486.
  18. Kanke, M., et al. (1983). Binding of selected drugs to a “treated” inline filter. Am. J. Hosp.Pharm. 40: 1323-1328.
  19. Khue, N. V., and Jung, L. (1985). Study of the retention of child-dose drugs on cellulose ester membranes during inline intravenous filtration. S-T-P Pharma. 1: 201-207.
  20. Boca, M.B., et al. (2005), A validated HPLC method for determining residues of a dual active ingredient anti-malarial drug on manufacturing equipment surfaces. J. Pharm. Biomed.Anal. 37:461-468.
  21. Maddus, M.S. , and Barrierre, S.L. (1980). A review of complications of amphotericin B therapy; recommendations for prevention and management. Drug Intell. Clin. Pharm. 14: 177-181.
  22. Ines, M., et al. (2006). Quantitative determination of gatifloxacin, levofloxacin, lomefloxacin and pefloxacin fluoroquinolonic antibodies in pharmaceutical preparations by high-performance liquid chromatography. J. Pharm.Biomed.Anal. 40: 179-184.
  23. Fantin, M., et al. (2006). Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties. European Journal of Pharmacology 535: 301-309.
  24. McEvoy, G. K. (Ed.) . (1991) American hospital formulary service drug information 91. American Society of Hospital Pharmacists.
  25. Ober, M.D. et al. (2006), Measurement of the Actual Dose of Triamcinolone Acetonide Delivered by Common Techniques of Intravitreal Injection. American Journal of Ophthalmology 142: 597-600.e1.
  26. Lofwall, M. R. ,et al. (2006). Cognitive and Subjective Acute Dose Effects of Intramuscular Ketamine in Healthy Adults. Experimental and Clinical Psychopharmacology 14: 439-449.
  27. Kato, M., et al. (2005) Examination of meningocele induced by the antitumor agent DE-310 in rat fetuses. Reproductive Toxicology 20: 495-502.28. Miles Pharm.
  28. Langer, O., et al. (2003). Synthesis of fluorine-18-labeled ciprofloxacin for PET studies in humans. Nuclear Medicine and Biology 30: 285-291.
  29. Pavlik, E. J., et al. (198e). Properties of anticancer agents relevant to in vitro determinations of human tumor cell sensitivity. Cancer Chemother. Pharmacol. 11: 8-15.
  30. Pavlik, E.J., et al. (1982) Sensitivity to anticancer agents in vitro: standardizing the cytotoxic response and characterizing the sensitivities of a reference cell line. Gynecol. Oncol. 14: 243-261.
  31. Oradell, N.J., 1991). Physicians’ Desk Reference. 45th edition.
  32. Rusmin, S., et al. (1977). Effect of inline filtration on the potency of drugs administered intravenously. Am.J. Hosp. Pharm. 34: 1071-1074.
  33. Rudaz, S., et al. (2003). Veuthey, Development and validation of a heart-cutting liquid chromatography-mass spectrometry method for the determination of process-related substances in cetirizine tablets. Analytica Chimica Acta 492: 271-282.
  34. Fazio, T.T., et al. (2007) Quantitative determination and sampling of azathioprine residues for cleaning validation in production area. J. Pharm. Biomed,Anal. 43: 1495-1498.
  35. Thompson, D. F., et al. (1984). Effect of inline filtration on pediatric doses of gentamicin and tobramycin. Infusion 8: 31-32.
  36. Tipple, M. et al. (1977). Availability of active amphotericin B after filtration through membrane filters. Am. Rev. Resp.Dis 115: 879-881.